Novo Nordisk can't keep up with demand for Ozempic and Wegovy, giving competitor Eli Lilly the edge in the GLP-1 market. And off-brand competitors continue to hammer the company's market position. Layoffs and board resignations signal that Novo Nordisk has entered a downward spiral. But with new leaders, acquisitions and deals, can they force a comeback?
Se ... Show More
Jun 2025
Breaking Bell | The Decision to Decide | 1
After almost a century of controlling the telecommunications industry in the United States, AT&T’s dominance is threatened by new competition. It’s a challenge that “Ma Bell” has weathered before, but this time is different—the political climate has changed, and the powerbrokers ... Show More
35m 38s
Jul 2025
Breaking Bell | The Deal | 4
As AT&T moves closer to being forcibly dismantled by the courts, bosses consider a radical alternative. But even when they press the button for the nuclear option, there’s no guarantee that their plan will succeed.Be the first to know about Wondery’s newest podcasts, curated reco ... Show More
34m 47s